HomeSHRX • CVE
add
Sharp Therapeutics Corp
Previous close
$2.20
Year range
$2.20 - $2.20
Market cap
620.86M CAD
Avg Volume
683.00
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.15M | 102.81% |
Net income | -1.81M | -110.53% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.15M | -113.77% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 233.88K | — |
Total assets | 1.39M | — |
Total liabilities | 15.90M | — |
Total equity | -14.51M | — |
Shares outstanding | 139.26K | — |
Price to book | -0.02 | — |
Return on assets | — | — |
Return on capital | -352.84% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -1.81M | -110.53% |
Cash from operations | -624.48K | -21.25% |
Cash from investing | -7.24K | -40.25% |
Cash from financing | 560.23K | -5.38% |
Net change in cash | -71.50K | -199.51% |
Free cash flow | — | — |
About
Founded
2021
Headquarters
Website
